Study Identifies Possible Cause of Rising Colorectal Cancer Rates Among Young People
Research published in Nature, co-authored by ICVS’s Rui M. Reis, paves the way for new strategies in prevention and treatment.
Category News
Read MoreStudy Identifies Possible Cause of Rising Colorectal Cancer Rates Among Young People
ICVS Study Highlights Potential of Plant Extract as a Source for Treating Neurodegenerative Diseases
Researchers from ICVS have discovered that compounds originated from the plant Hemerocallis citrina Baroni could have therapeutic potential for treating neurodegenerative diseases like Machado-Joseph Disease (MJD/SCA3) and Frontotemporal Dementia with Parkinsonism (FTDP-17). These diseases are characterized by the loss of neurons and severe motor difficulties.
NLX-101: A Breath of Fresh Air for Patients with Rett Syndrome
Researchers at the Life and Health Sciences Research Institute (ICVS) of the University of Minho have taken an important step in the search for new therapies for Rett Syndrome, a rare neurological disorder that still lacks an effective treatment. The results of the study, now published in the prestigious journal Biomedicine & Pharmacotherapy, show that the experimental drug NLX-101 may alleviate two of the most severe symptoms: irregular breathing and cognitive difficulties.
Malaria Becomes Harder to Treat Due to Multiple Mutations
Malaria is proving more difficult to treat than previously thought, as drug resistance is linked to multiple genetic mutations in the parasite rather than a single one. This is the conclusion of an international study involving scientists from ICVS published in Nature Communications.
ICVS Receives “Excellent” Rating in National FCT Evaluation
The Life and Health Sciences Research Institute (ICVS) has been awarded the highest classification of EXCELLENT in the most recent national evaluation of R&D Units, conducted by the Fundação para a Ciência e a Tecnologia (FCT) under the Multiannual Funding Programme for 2023/2024.
ICVS Researcher Filipa Antunes Wins ART 3R Award for Innovative Parkinson’s Therapy
Filipa Antunes, a researcher at ICVS, has won the ART 3R Award for 2025. Her project, "Intranasal Administration as a Minimally Invasive Alternative for Stem Cell-Based Parkinson’s Disease Therapy in Rodents," has been awarded a €3,000 grant to explore a more humane and cost-effective method for treating Parkinson’s disease in animal models.
ICVS Researchers Join Innovative GALActIC Study to Combat IAPA
ICVS is a contributing partner in the launch of GALActIC, a pioneering European Union research project aimed at tackling Influenza-associated Pulmonary Aspergillosis (IAPA). The study, led by a European consortium, is funded by the European Partnership for Personalised Medicine (EP PerMed) and promises to pave the way for more effective identification and treatment of this severe condition.
ICVS and INL Researchers Develop New Electrical Stimulator to Boost Cell Research
Researchers from ICVS and INL have developed an innovative multi-channel electrical stimulator designed to advance in vitro cellular research. This innovative device enables precise electrical stimulation of cells, promoting axonal growth and guiding stem cell differentiation, key processes in regenerative medicine and therapy development.
Serotonin in the Gut: A Promising Approach to Modulate Depression and Anxiety
ICVS Researcher Nuno Dinis Alves Explored the Role of Gut Serotonin in Treating Depression and Anxiety While Reducing Side Effects of Classic Antidepressants
ICVS Researchers Win ESCMID Grants for Infectious Disease and Immunology Research
Three researchers from ICVS have been awarded ESCMID grants for their research into infectious diseases and immunology. João do Canto Gomes, Samuel Gonçalves and Vitória Baptista will receive support to advance their innovative projects.
